About Sarah Cannon Research Institute UK
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Sarah Cannon Research Institute UK
During the past decade, Sarah Cannon Research Institute UK conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 17 clinical trials were completed, i.e. on
average, 30.9% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 12 clinical trials were completed. i.e. 57.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors
2005-12-01
2014-06-01
Completed
48
Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer
2007-07-01
2011-06-01
Completed
20
A Study of PRO95780 in Patients With Advanced Chondrosarcoma (APM4171g)
2007-05-31
2008-05-05
Terminated
15
ABI-009 Trial in Patients With Advanced Non-hematologic Malignancies
2007-12-01
2011-06-01
Completed
27
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Sarah Cannon Research Institute UK" #1 sponsor was "Pfizer" with 8 trials, followed by "Seagen Inc." with 8 trials
sponsored, "BeiGene" with 6 trials sponsored, "Celgene" with 6 trials sponsored and "Daiichi Sankyo, Inc."
with 6 trials sponsored. Other sponsors include 29 different institutions and
companies that sponsored additional 27 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Sarah Cannon Research Institute UK"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 5 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Celgene Corporation" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator and "Medivation, Inc." with 2 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at Sarah Cannon Research Institute UK
According to Clinical.Site data, the most researched conditions in "Sarah Cannon Research Institute UK" are
"Breast Cancer" (6 trials), "Ovarian Cancer" (6 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials), "Advanced Cancer" (3 trials) and "Advanced Solid Tumor" (3 trials). Many other conditions were trialed in "Sarah Cannon Research Institute UK" in a lesser frequency.
Clinical Trials Intervention Types at Sarah Cannon Research Institute UK
Most popular intervention types in "Sarah Cannon Research Institute UK" are "Drug" (62 trials), "Biological" (5 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Avelumab" (4 trials), "Gemcitabine" (4 trials), "Irinotecan" (4 trials) and "tucatinib" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Sarah Cannon Research Institute UK
The vast majority of trials in "Sarah Cannon Research Institute UK" are
61 trials for "All" genders, 4 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Sarah Cannon Research Institute UK
Currently, there are NaN active trials in "Sarah Cannon Research Institute UK".
undefined are not yet recruiting,
16 are recruiting,
23 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 23 completed trials in Sarah Cannon Research Institute UK,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Sarah Cannon Research Institute UK, 29 "Phase 1"
clinical trials were conducted, 34 "Phase 2" clinical
trials and 17 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".